GO:0006661 phosphatidylinositol biosynthetic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006661 describes the chemical reactions and pathways that build phosphatidylinositol (PtdIns), a glycophospholipid with sn-glycerol 3-phosphate esterified to the 1-hydroxyl group of 1D-myo-inositol.
• Phosphatidylinositol is the precursor of all phosphoinositides, which regulate membrane traffic, signal transduction, and nuclear lipid signalling.
• The pathway is conserved and involves sequential acylation and cytidylyltransferase reactions that convert phosphatidic acid to PtdIns.
• Phosphoinositide phosphatases and kinases dynamically remodel PtdIns-derived lipids, and their dysregulation is linked to cancer and myotubular myopathy.
• Recent work shows phosphoinositides and cholesterol regulate STING activation, connecting PtdIns biosynthesis to innate immunity.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of genes in this pathway.
Description
Phosphatidylinositol (PtdIns) is a minor but essential membrane phospholipid that serves as the metabolic hub for all phosphoinositide signalling. The Gene Ontology term GO:0006661, phosphatidylinositol biosynthetic process, captures the enzymatic steps that assemble this lipid from phosphatidic acid and inositol precursors. Because PtdIns and its phosphorylated derivatives control membrane identity, vesicle trafficking, and nuclear signalling, the pathway is central to cell biology and disease research. This article integrates the QuickGO definition with verified literature to outline the mechanism, key genes, regulation, disease links, and CRISPR-based research strategies for GO:0006661.
phosphatidylinositol biosynthetic process At A Glance
| GO ID | GO:0006661 |
|---|---|
| GO term | phosphatidylinositol biosynthetic process |
| Ontology | biological_process |
| Synonym | phosphatidylinositol anabolism; phosphatidylinositol biosynthesis; phosphatidylinositol formation; phosphatidylinositol synthesis; phosphoinositide biosynthesis; phosphoinositide biosynthetic process; PtdIns biosynthesis; PtdIns biosynthetic process |
| Major function | Synthesis of phosphatidylinositol, the precursor of all phosphoinositides involved in signalling and membrane traffic |
| Pathway location | Endoplasmic reticulum and associated membranes |
| Key enzymes | CDP-diacylglycerol-inositol 3-phosphatidyltransferase (PIS), phosphatidylinositol synthases, and lipid kinases/phosphatases |
| Related processes | Phosphoinositide phosphorylation, membrane trafficking, nuclear lipid signalling |
What Is GO:0006661?
GO:0006661 is defined as the chemical reactions and pathways resulting in the formation of phosphatidylinositol, any glycophospholipid in which the sn-glycerol 3-phosphate residue is esterified to the 1-hydroxyl group of 1D-myo-inositol. In simpler terms, it is the biosynthetic route that produces PtdIns, the parent lipid for phosphoinositide signalling.
Why Is phosphatidylinositol biosynthetic process Important in Cell Biology?
Phosphatidylinositol biosynthesis is fundamental because PtdIns is the substrate for phosphoinositide kinases and phosphatases that generate signalling lipids such as PI(4,5)P2, PI(3,4,5)P3, and PI(3)P. These lipids control constitutive membrane traffic, endosomal sorting, and nuclear signalling, and their dysregulation contributes to cancer, myotubular myopathy, and immune disorders.
• Provides the precursor for all phosphoinositides, which regulate membrane trafficking and signal transduction.
• Supports nuclear lipid signalling that influences transcription and cell cycle progression.
• Phosphoinositide phosphatases such as myotubularin police 3-phosphoinositide levels, and their loss causes disease.
• Altered phosphoinositide metabolism is observed in multiple cancers.
• Phosphoinositides and cholesterol regulate STING activation, linking PtdIns biosynthesis to innate immunity.
• The pathway is essential for constitutive membrane traffic in eukaryotic cells.
• Phosphoinositide synthesis can occur via alternative routes, including kinase-independent mechanisms.
• F-actin capping proteins interact with phosphoinositides, connecting the pathway to cytoskeletal dynamics.
What Happens During phosphatidylinositol biosynthetic process?
Activation of phosphatidic acid to CDP-diacylglycerol
In simple terms: The cell first converts phosphatidic acid into an activated intermediate called CDP-diacylglycerol.
The biosynthetic route begins with phosphatidic acid, which is converted to CDP-diacylglycerol by CDP-diacylglycerol synthase. This step activates the lipid for subsequent transfer of the phosphatidyl group to inositol. The reaction occurs at the endoplasmic reticulum and provides the committed precursor for PtdIns formation.
Transfer of phosphatidyl group to inositol
In simple terms: An enzyme attaches the phosphatidyl group to inositol, forming phosphatidylinositol.
CDP-diacylglycerol-inositol 3-phosphatidyltransferase (PIS) catalyzes the transfer of the phosphatidyl moiety from CDP-diacylglycerol to 1D-myo-inositol, yielding phosphatidylinositol and CMP. This reaction defines the core of GO:0006661 and is conserved from yeast to humans.
Remodeling and phosphorylation to phosphoinositides
In simple terms: Once made, phosphatidylinositol can be phosphorylated at different positions to create signalling lipids.
PtdIns is subsequently phosphorylated by phosphoinositide kinases to generate PI(4)P, PI(4,5)P2, PI(3)P, and other phosphoinositides. These lipids are dephosphorylated by phosphatases such as myotubularin, which police 3-phosphoinositide levels. Alternative phosphorylation routes that do not require canonical kinases have also been described.
Membrane trafficking and nuclear signalling
In simple terms: The phosphoinositides made from PtdIns help move membranes and send signals inside the cell.
Phosphoinositides produced from PtdIns regulate constitutive membrane traffic, including vesicle formation and fusion. In the nucleus, phosphoinositide signalling influences transcription and cell cycle progression. Recent evidence shows phosphoinositides and cholesterol regulate STING activation, linking PtdIns metabolism to innate immune signalling.
Key Genes Involved in GO:0006661 phosphatidylinositol biosynthetic process
The following genes and proteins are experimentally implicated in phosphatidylinositol biosynthesis and its downstream phosphoinositide metabolism.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CDS1 | CDP-diacylglycerol synthase, converts phosphatidic acid to CDP-diacylglycerol | Rate-limiting step in PtdIns biosynthesis |
| CDS2 | CDP-diacylglycerol synthase isoform | Provides substrate for PIS |
| PIS1 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase, forms PtdIns | Core enzyme of GO:0006661 |
| PIS2 | Phosphatidylinositol synthase isoform | Alternative route for PtdIns synthesis |
| PI4KA | Phosphatidylinositol 4-kinase alpha, generates PI(4)P | Phosphoinositide signalling and trafficking |
| PI4KB | Phosphatidylinositol 4-kinase beta | Membrane traffic and Golgi function |
| PIP5K1A | Phosphatidylinositol-4-phosphate 5-kinase, generates PI(4,5)P2 | Signalling and cytoskeletal regulation |
| PTEN | Lipid phosphatase that dephosphorylates PI(3,4,5)P3 | Tumor suppressor, cancer biology |
| MTM1 | Myotubularin phosphatase, dephosphorylates PI(3)P | Myotubular myopathy |
| MTMR2 | Myotubularin-related phosphatase | Peripheral neuropathy and phosphoinositide regulation |
| INPP4A | Inositol polyphosphate-4-phosphatase | Phosphoinositide turnover |
| INPP4B | Inositol polyphosphate-4-phosphatase type II | Tumor suppressor candidate |
| STING1 | Stimulator of interferon genes, regulated by phosphoinositides and cholesterol | Innate immunity |
| CAPZA1 | F-actin capping protein subunit, interacts with phosphoinositides | Cytoskeletal dynamics |
| CAPZB | F-actin capping protein subunit | Actin regulation |
| PIP4K2A | Phosphatidylinositol-5-phosphate 4-kinase | Phosphoinositide synthesis |
| OCRL | Inositol polyphosphate 5-phosphatase | Lowe syndrome and phosphoinositide metabolism |
How Is phosphatidylinositol biosynthetic process Regulated?
Phosphatidylinositol biosynthesis is regulated by the availability of phosphatidic acid and inositol, and by feedback from downstream phosphoinositides. Phosphoinositide phosphatases such as myotubularin and PTEN counteract kinase activities, maintaining lipid homeostasis. Nuclear lipid signalling adds a layer of spatial regulation, with phosphoinositides influencing transcription independently of membrane pools. Recent work indicates that cholesterol and phosphoinositides cooperate to regulate STING activation, showing that PtdIns metabolism is integrated with immune signalling.
phosphatidylinositol biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PTEN | Cancer (tumor suppressor loss) | Knockout in cancer cell lines; point mutation of catalytic residue |
| MTM1 | X-linked myotubular myopathy | Knockout in muscle cells; knock-in of patient mutations |
| MTMR2 | Charcot-Marie-Tooth neuropathy | Knockout in Schwann cells; overexpression of mutant |
| STING1 | Autoinflammatory interferonopathies | Knock-in of gain-of-function alleles; knockout for loss-of-function |
| OCRL | Lowe syndrome | Knockout in fibroblasts; point mutation of phosphatase domain |
Cancer
Altered phosphoinositide phosphatase activity is frequently observed in cancer, where loss of PTEN or INPP4B leads to accumulation of PI(3,4,5)P3 and enhanced growth signalling. Because PtdIns is the precursor of these lipids, changes in its biosynthesis can indirectly influence oncogenic pathways.
Myotubular myopathy and neuropathy
Mutations in myotubularin (MTM1) cause X-linked myotubular myopathy, and related phosphatases such as MTMR2 are linked to peripheral neuropathies. These enzymes dephosphorylate 3-phosphoinositides produced from PtdIns, highlighting the importance of the pathway in muscle and nerve function.
Innate immunity and STING
Phosphoinositides and cholesterol regulate STING activation, connecting PtdIns biosynthesis to interferon responses and antiviral immunity. Dysregulation of this axis may contribute to autoinflammatory conditions.
From phosphatidylinositol biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is PIS1 essential for PtdIns biosynthesis? | CRISPR knockout of PIS1 in HEK293 or HeLa cells |
| Does a point mutation in CDS1 alter lipid flux? | Point-mutation knock-in of catalytic residues |
| How does PTEN loss affect phosphoinositide levels? | PTEN knockout or point-mutation knock-in |
| Can tagged PIS1 reveal subcellular localization? | Tagged knock-in of PIS1 with GFP or HA |
| Does overexpression of PI4KA increase PI(4)P? | Overexpression of PI4KA in stable cell lines |
| Which genes regulate STING activation via phosphoinositides? | CRISPR library screening targeting lipid metabolic genes |
How to Study the phosphatidylinositol biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipidomics (LC-MS) | Levels of PtdIns and phosphoinositides | Pathway flux and disease models |
| Fluorescence microscopy | Subcellular localization of phosphoinositides | Membrane trafficking studies |
| CRISPR knockout screening | Gene essentiality for PtdIns synthesis | Discovery of novel regulators |
| Enzyme activity assay | PIS or phosphatase catalytic rate | Functional validation of mutations |
| Immunoblotting | Protein expression of pathway enzymes | Knockout/overexpression validation |
| RNA-seq | Transcriptional changes in lipid genes | Response to metabolic stress |
| Proteomics | Protein interactions with phosphoinositides | Identification of binding partners |
| STING reporter assay | Innate immune activation | Phosphoinositide-STING crosstalk |
Lipidomics and mass spectrometry
Mass spectrometry-based lipidomics quantifies phosphatidylinositol and its phosphorylated derivatives, providing direct readouts of pathway activity.
Fluorescence imaging of phosphoinositide probes
Genetically encoded biosensors and fluorescent probes visualize phosphoinositide distribution in live cells, revealing membrane trafficking defects.
CRISPR screening and functional genomics
Pooled CRISPR knockout screens identify genes required for PtdIns biosynthesis and downstream signalling, enabling unbiased discovery.
Biochemical enzyme assays
In vitro assays measure phosphatidylinositol synthase and phosphatase activities using radiolabeled or fluorescent substrates.
How CRISPR Can Be Used to Study GO:0006661 phosphatidylinositol biosynthetic process
Knockout
CRISPR knockout of genes such as PIS1, CDS1, or PTEN eliminates protein function and reveals their requirement for phosphatidylinositol biosynthesis and downstream signalling.
Point Mutation
Point-mutation knock-in of catalytic residues in PIS1 or PTEN allows precise testing of enzymatic activity without confounding effects of protein loss.
Knock-in
Tagged knock-in of endogenous PIS1 or PI4KA with fluorescent or affinity tags enables visualization and purification of pathway components under native regulation.
Overexpression
Overexpression of PI4KA, PIP5K1A, or STING1 increases specific phosphoinositide pools or immune signalling, allowing gain-of-function studies.
How EDITGENE Supports phosphatidylinositol biosynthetic process Research
Researchers studying phosphatidylinositol biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in lipid synthesis, trafficking, or disease. EDITGENE provides tailored CRISPR cell models to test these hypotheses with precision.
Contact EDITGENE today to design your custom CRISPR model for phosphatidylinositol biosynthetic process research.
Frequently Asked Questions About phosphatidylinositol biosynthetic process
What is phosphatidylinositol biosynthetic process?
It is the metabolic pathway that produces phosphatidylinositol, a glycophospholipid precursor for all phosphoinositides, as defined by GO:0006661.
What genes are involved in phosphatidylinositol biosynthetic process?
Key genes include CDS1, CDS2, PIS1, PIS2, PI4KA, PI4KB, PIP5K1A, PTEN, MTM1, and MTMR2.
What is the function of phosphatidylinositol?
Phosphatidylinositol serves as a precursor for phosphoinositides that regulate membrane trafficking, signal transduction, and nuclear signalling.
Where does phosphatidylinositol biosynthesis occur?
The core reactions occur at the endoplasmic reticulum, and downstream phosphorylation occurs on various membranes.
How is phosphatidylinositol biosynthesis regulated?
It is regulated by substrate availability, feedback from phosphoinositides, and the opposing activities of kinases and phosphatases such as myotubularin and PTEN.
What diseases are linked to phosphatidylinositol biosynthesis?
Dysregulation is linked to cancer, myotubular myopathy, peripheral neuropathy, and innate immune disorders involving STING.
How can CRISPR be used to study phosphatidylinositol biosynthesis?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes in the pathway.
What methods measure phosphatidylinositol levels?
Lipidomics, fluorescence microscopy with phosphoinositide probes, and enzyme activity assays are commonly used.
Is phosphatidylinositol involved in immunity?
Yes, phosphoinositides and cholesterol regulate STING activation, linking the pathway to innate immunity.
What is the GO ID for phosphatidylinositol biosynthetic process?
The GO ID is GO:0006661.
Conclusion
GO:0006661 phosphatidylinositol biosynthetic process is a central metabolic pathway that supplies the precursor for all phosphoinositide signalling lipids. Its enzymes and regulators are implicated in cancer, myotubular myopathy, neuropathy, and innate immunity. CRISPR-based models provide powerful tools to dissect the causal roles of these genes, and EDITGENE offers comprehensive services to accelerate such research.
References
- 1. Li J et al.. 2026. Regulation of STING activation by phosphoinositide and cholesterol.. Nature 652(8109):499-507 PMID: 41639452
- 2. Weeds A et al.. 1993. F-actin capping proteins.. Curr Opin Cell Biol 5(1):63-9 PMID: 8383512
- 3. Rudge SA et al.. 2016. Phosphatidylinositolphosphate phosphatase activities and cancer.. J Lipid Res 57(2):176-92 PMID: 26302980
- 4. Cao X et al.. 2022. Phosphoinositide phosphorylation sans kinase.. Nat Cell Biol 24(5):604-606 PMID: 35484248
- 5. Tolias KF et al.. 1999. Pathways for phosphoinositide synthesis.. Chem Phys Lipids 98(1-2):69-77 PMID: 10358929
- 6. Irvine RF. 2003. Nuclear lipid signalling.. Nat Rev Mol Cell Biol 4(5):349-60 PMID: 12728269
- 7. Robinson FL et al.. 2006. Myotubularin phosphatases: policing 3-phosphoinositides.. Trends Cell Biol 16(8):403-12 PMID: 16828287
- 8. Roth MG. 2004. Phosphoinositides in constitutive membrane traffic.. Physiol Rev 84(3):699-730 PMID: 15269334
